XML 210 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Operating Activities        
Net (loss) $ (3,922) $ (2,907) $ (22,268) $ (13,290)
Adjustments to reconcile net loss to net cash: (used in) provided by operating activities        
Depreciation 273 180 872 561
Allowance for doubtful accounts   191 194 158
Inventories impairment 234   1,689 0
Non-cash lease expense 39 26 (26) 102
Inventory casualty losses       1,376
Deferred income tax expense 29   (72) 1,200
Share-based compensation   87 14,061 644
Non-cash PIK interest   21 30 83
(Gain) on sale of equipment   (17) (18)  
Loss on financing transaction 876   4,043  
Change in fair value of warrants liabilities (29)   (195)  
Loss (gain) in fair value of convertible notes 475 (287) (970)  
Increase (decrease) in cash resulting from changes in:        
Trade accounts receivable 1,763 554 (928) (211)
Deferred transaction costs (483) (1,633) (1,098)  
Inventories 464 (89) 372 284
Other current assets 107 1,254 1,144 1,306
Other noncurrent assets       (1)
Trade accounts payable 1,583 1,765 (14) 461
Income taxes payable 1,565 9 480 511
Income taxes receivable 3 (39) 1 1,645
Contract liability (1,028) (66) 1,657 212
Other current liabilities (18) (59) (110) (14)
Right of use liabilities (36) (24) (163) (105)
Accrued expenses (1,286) 475 (3,343) 1,897
Other liabilities     111 11
Net cash (used in) provided by operating activities 492 (418) (4,551) (3,170)
Investing Activities        
Capital expenditures (571) (537) (1,542) (1,600)
Proceeds from sale of equipment   30 30  
Net cash used in investing activities (571) (507) (1,512) (1,600)
Financing Activities        
Repayments of line of credit     (900)  
Proceeds from stockholder promissory notes       200
Repayments on stockholder promissory notes     (100) (100)
Proceeds from convertible notes   150 1,806 950
Proceeds from financing transaction     4,481  
Merger recapitalization     (2,344)  
Net cash (used in) provided by financing activities (585) 350 6,564 2,050
Net decrease in cash and cash equivalents (664) (575) 501 (2,720)
Cash and cash equivalents, beginning of period 1,155 654 654 3,374
Cash and cash equivalents, end of the period 491 79 1,155 654
Supplemental cash flow information        
Interest paid 4   52 29
Income taxes paid   27 6 33
Non-cash investing and financing transactions        
Conversion of stockholder promissory note and accrued interests into common stock     18,501  
Conversion of convertible notes and accrued interest into common stock 4,475   2,054  
Conversion of related party promissory note into convertible notes     1,000  
Transfer of inducement shares in financing transaction 876   4,641  
Legacy SMAP        
Non-cash investing and financing transactions        
Conversion of related party promissory note into convertible notes     1,324  
Related Party        
Financing Activities        
Borrowings from related party promissory note     575 1,000
Legacy SMAP        
Financing Activities        
Borrowings from related party promissory note     1,524  
First Insurance Funding        
Financing Activities        
Borrowings under line of credit     647  
Repayments of line of credit $ (385)   (25)  
Wells Fargo        
Financing Activities        
Borrowings under line of credit       1,400
Repayments of line of credit       $ (1,400)
B1 Bank        
Financing Activities        
Borrowings under line of credit   $ 300 900  
Repayments of line of credit     $ (900)